Merck & Co., Inc. (LON:MRK)
London flag London · Delayed Price · Currency is GBP · Price in GBX
59.50
+1.00 (1.71%)
Mar 31, 2025, 1:27 PM BST

Merck & Co. Company Description

Merck & Co., Inc. operates as a healthcare company worldwide.

It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands.

It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands.

The company has development and commercialization agreement for three of Daiichi Sankyo’s deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca’s Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Merck & Co., Inc.
Country United States
Founded 1891
Industry Specialty Retail
Sector Consumer Discretionary
Employees 75,000
CEO Robert Davis

Contact Details

Address:
126 East Lincoln Avenue
Rahway, New Jersey 07065
United States
Phone 908 740 4000
Website merck.com

Stock Details

Ticker Symbol MRK
Exchange London Stock Exchange
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
ISIN Number GB00BM8Q5G47
SIC Code 2834

Key Executives

Name Position
Mark Adrian Smithson Founder, Chief Executive Officer and Director
Joshua Ellis Thomas Allan Egan Chief Financial Officer and Director
Andy Swann Sales Manager
Heather Southam Head of Human Resources
Alan Graves Head of IT
Mike Copson Head of Financial Reporting